Literature DB >> 3977711

Autosomal dominant retinitis pigmentosa. A method of classification.

G A Fishman, K R Alexander, R J Anderson.   

Abstract

Four types of autosomal dominant retinitis pigmentosa (RP) were discernible in 84 patients by clinical, electrophysiologic, and psychophysical criteria. Type 1 patients showed diffuse fundus pigmentary changes and nondetectable electroretinographic (ERG) cone and rod functions. Both type 2 and type 3 patients showed fundus pigmentary changes more apparent within the inferior retina. Type 2 patients showed marked loss in rod ERG function, with prolonged cone implicit times, whereas type 3 patients showed substantial rod function and normal cone implicit times. Type 4 patients had a funduscopically and functionally "delimited" disease, with substantial cone and rod ERG amplitudes and normal implicit times. The classification of dominantly inherited RP is important for studies of natural history in disease progression, for patient counseling, and for various laboratory investigations of patients with RP in which patient homogeneity should be maximized.

Entities:  

Mesh:

Year:  1985        PMID: 3977711     DOI: 10.1001/archopht.1985.01050030062023

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  15 in total

1.  Ocular findings in patients with autosomal dominant retinitis pigmentosa and Cys110Phe, Arg135Gly, and Gln344stop mutations of rhodopsin.

Authors:  S Kremmer; A Eckstein; A Gal; E Apfelstedt-Sylla; H Wedemann; K Rüther; E Zrenner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

2.  Novel rhodopsin mutations and genotype-phenotype correlation in patients with autosomal dominant retinitis pigmentosa.

Authors:  A Schuster; N Weisschuh; H Jägle; D Besch; A R Janecke; H Zierler; S Tippmann; E Zrenner; B Wissinger
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

3.  Clinical and ERG data in a family with autosomal dominant RP and Pro-347-Arg mutation in the rhodopsin gene.

Authors:  G Niemeyer; P Trüb; A Schinzel; A Gal
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

4.  Low-noise electroretinogram recording techniques in retinitis pigmentosa.

Authors:  E Rispoli; A Iannaccone; E M Vingolo
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

5.  Ocular findings in a family with autosomal dominant retinitis pigmentosa and a frameshift mutation altering the carboxyl terminal sequence of rhodopsin.

Authors:  E Apfelstedt-Sylla; M Kunisch; M Horn; K Rüther; H Gerding; A Gal; E Zrenner
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

6.  Autosomal dominant retinitis pigmentosa: a log quotient analysis of the photopic and scotopic b-wave amplitude.

Authors:  H Iijima; D A Martin; J R Heckenlively
Journal:  Br J Ophthalmol       Date:  1989-05       Impact factor: 4.638

7.  Correlations between electroretinography, morphology and function in retinitis pigmentosa.

Authors:  M Fahle; K P Steuhl; E Aulhorn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

8.  Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations.

Authors:  Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Elizabeth A M Windsor; Waldo Herrera; D Alan White; Shalesh Kaushal; Anjani Naidu; Alejandro J Roman; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

9.  Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man.

Authors:  A V Cideciyan; D C Hood; Y Huang; E Banin; Z Y Li; E M Stone; A H Milam; S G Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study.

Authors:  A T Moore; F Fitzke; M Jay; G B Arden; C F Inglehearn; T J Keen; S S Bhattacharya; A C Bird
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.